Vanguard Group’s Cubist Pharmaceuticals CBST Stock Holding History
Bought
Maintained
Sold
Vanguard Group's CBST Position: Q1 2015 in Review
Vanguard Group sold out of Cubist Pharmaceuticals (CBST) in Q1 2015, closing a stake of 4,709,941 shares — an estimated $474M sold.
Vanguard Group first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $474M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.
- Vanguard Group reported no remaining Cubist Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- Vanguard Group sold 4,709,941 Cubist Pharmaceuticals shares in Q1 2015, an estimated $474M.
- Vanguard Group first reported a position in Cubist Pharmaceuticals in Q2 2013 and held it in 7 quarters.
- Vanguard Group's Cubist Pharmaceuticals position peaked at $474M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Cubist Pharmaceuticals as of Q1 2015.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.